Analysis of Inter Partes Review and Post-Grant Review in the Life Sciences Industry Through First Quarter 2015

Published date13 May 2015
Law FirmTroutman Pepper
AuthorRaymond Miller,N. Nicole Stakleff
Subject MatterAmerica Invents Act,Generic Drugs,Hedge Funds,Intellectual Property Litigation,IPR,Jurisdiction,Life Sciences,Patent Trial and Appeal Board,Patents,Pharmaceutical,Pharmaceutical Manufacturers,Pharmaceutical Patents,Post-Grant Review,Stocks

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT